Hemodialysis patients with renal anemia
Conditions
Interventions
Continuous Erythropoietin Receptor Activator (CERA) once a month
Novel Erythropoiesis Stimulating Protein (NESP) once a week
Sponsors
Blood Purification Center, Mie University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Hemodialysis patients treated with NESP once a week Keep hemoglobin level between 10 to 12g/dl for 3 months before entry Patient who is obtaining written agreement by free will of patient himself after enough informed consent
Exclusion criteria
Exclusion criteria: Hemodialysis vintage less than 6 months Inpatient Patient who received transfusion within six months Anemic patient who has another cause of renal anemia like hematological or gastrointestinal diseases Patient who has poor prognostic malignancy Patient who can not agree with the study Patient who was judged inadequate case for the study by doctor
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Frequency that hemoglobin level becomes out of target range (10-12g/dl) for six months evaluation period . Frequency that hemoglobin level becomes over 12g/dl for six months evaluation period. Average value and coefficient of variance of hemoglobin for six months evaluation period. Frequency that hemoglobin level becomes less than 10g/dl for 12 months study period. Frequency that hemoglobin level becomes out of target range (10-12g/dl) for 12 months study period . Complications (death, new onset of cardiovasculr disease, and vascular access failure) | — |
Primary
| Measure | Time frame |
|---|---|
| Frequency that hemoglobin level becomes less than 10g/dl for six months evaluation period (12 times of observation). | — |
Countries
Japan
Contacts
Public ContactEiji Ishikawa
Mie University Hospital Blood Purification Center
Outcome results
None listed